Table 1. Characteristics of a Random Sample of Men Diagnosed With Prostate Cancer in Florida, 2002-2007 (N = 11,083).
Stage |
|||
---|---|---|---|
Variable | Earlya | Latea | p |
Age at diagnosis, years | 66.31 [8.81] | 66.30 [10.05] | .9859 |
Race | |||
White | 8,560 (88%) | 1,183(12%) | <.0001 |
Black | 1,119 (84%) | 221 (16%) | |
Marital status | |||
Unmarried | 1,921(83%) | 386 (17%) | <.0001 |
Married | 7,758 (88%) | 1,018 (12%) | |
Smoking | |||
Noncurrent smokers | 8,201(88%) | 1,108 (12%) | <.0001 |
Current smokers | 1,478 (83%) | 296 (17%) | |
Insurance | |||
Privately insured | 3,994(88%) | 558 (12%) | <.0001 |
Publicly insured | 5,531(88%) | 789 (12%) | |
Uninsured | 154 (73%) | 57 (27%) | |
For-profit facility | |||
No | 7,034 (87%) | 1,091(13%) | <.0001 |
Yes | 2,645 (89%) | 313 (11%) | |
Facility type | |||
Hospital | 9,390 (87%) | 1,397 (13%) | <.0001 |
Ambulatory | 289 (98%) | 7 (2%) | |
Year of diagnosis | |||
2002 | 1,995 (88%) | 281(12%) | .7856 |
2003 | 1,431(88%) | 189 (12%) | |
2004 | 1,459(87%) | 219 (13%) | |
2005 | 1,456 (87%) | 218 (13%) | |
2006 | 1,621(87%) | 244 (13%) | |
2007 | 1,717 (87%) | 253 (13%) | |
Congestive heart failure | |||
No | 9,513(88%) | 1,334(12%) | <.0001 |
Yes | 166 (70%) | 70 (30%) | |
Valvular disease | |||
No | 9,417 (87%) | 1,350 (13%) | .0165 |
Yes | 262 (83%) | 54 (17%) | |
Pulmonary circulation disease | |||
No | 9,651(87%) | 1,394(13%) | .0230 |
Yes | 28 (74%) | 10 (26%) | |
Peripheral vascular disease | |||
No | 9,491(87%) | 1,367(13%) | .0853 |
Yes | 188 (84%) | 37 (16%) | |
Paralysis | |||
No | 9,650 (87%) | 1,386(13%) | <.0001 |
Yes | 29 (62%) | 18 (38%) | |
Other neurological disorders | |||
No | 9,548(87%) | 1,379 (13%) | .2042 |
Yes | 131(84%) | 25(16%) | |
Chronic pulmonary disease | |||
No | 8,798 (88%) | 1,244 (12%) | .0059 |
Yes | 881(85%) | 160 (15%) | |
Diabetes with/without chronic complications | |||
No | 8,619 (87%) | 1,252 (13%) | .8882 |
Yes | 1060 (87%) | 152 (13%) | |
Diabetes with chronic complications | |||
No | 9,614 (87%) | 1,385(13%) | .0059 |
Yes | 65 (77%) | 19 (23%) | |
Hypothyroidism | |||
No | 9,447(87%) | 1,365(13%) | .3879 |
Yes | 232 (86%) | 39 (14%) | |
Renal failure | |||
No | 9,501(88%) | 1,333(12%) | <.0001 |
Yes | 178 (71%) | 71(29%) | |
Liver disease | |||
No | 9,631(87%) | 1,388 (13%) | .0029 |
Yes | 48 (75%) | 16 (25%) | |
Peptic ulcer disease excluding bleeding | |||
No | 9,653(87%) | 1,400 (13%) | .7868 |
Yes | 26 (87%) | 4 (13%) | |
Acquired immune deficiency syndrome | |||
No | 9,669 (87%) | 1,401(13%) | .2218 |
Yes | 10 (77%) | 3 (23%) | |
Lymphoma | |||
No | 9,623(87%) | 1,396 (13%) | .9677 |
Yes | 56 (88%) | 8 (12%) | |
Metastatic cancer | |||
No | 9,440 (89%) | 1,192 (11%) | <.0001 |
Yes | 239 (53%) | 212 (47%) | |
Solid tumor with/without metastasis | |||
No | 9,125 (87%) | 1,340 (13%) | .0754 |
Yes | 554 (90%) | 64 (10%) | |
Rheumatoid arthritis/collagen vas | |||
No | 9,628 (87%) | 1,396 (13%) | .8365 |
Yes | 51(86%) | 8 (14%) | |
Coagulopathy | |||
No | 9,576 (88%) | 1,354 (12%) | <.0001 |
Yes | 103 (67%) | 50 (33%) | |
Obesity | |||
No | 9,460 (87%) | 1,369 (13%) | .5900 |
Yes | 219 (86%) | 35 (14%) | |
Weight loss | |||
No | 9,636 (88%) | 1,361 (12%) | <.0001 |
Yes | 43 (50%) | 43 (50%) | |
Fluid and electrolyte disorders | |||
No | 9,250 (89%) | 1,183 (11%) | <.0001 |
Yes | 429 (66%) | 221 (34%) | |
Blood loss anemias | |||
No | 9,609 (87%) | 1,374 (13%) | <.0001 |
Yes | 70 (70%) | 30 (30%) | |
Deficiency anemias | |||
No | 9,297 (89%) | 1,193 (11%) | <.0001 |
Yes | 382 (64%) | 211 (36%) | |
Alcohol abuse | |||
No | 9,600 (88%) | 1,368 (12%) | <.0001 |
Yes | 79 (69%) | 36 (31%) | |
Drug abuse | |||
No | 9,668 (87%) | 1,399 (13%) | .0426 |
Yes | 11(69%) | 5 (31%) | |
Psychoses | |||
No | 9,630 (87%) | 1,386 (13%) | .0005 |
Yes | 49 (73%) | 18 (27%) | |
Depression | |||
No | 9,485 (87%) | 1,360 (13%) | .0064 |
Yes | 194 (82%) | 44 (18%) | |
Hypertension (combined uncomplicated and complicated) | |||
No | 5,411(88%) | 741 (12%) | .0276 |
Yes | 4,268 (87%) | 663 (13%) | |
Endocrine disorders, nutritional and metabolic, immunity | |||
No | 7,734 (88%) | 1,063 (12%) | .0003 |
Yes | 1,945 (85%) | 341 (15%) | |
Ischemic heart disease | |||
No | 8,383 (88%) | 1,186 (12%) | .0293 |
Yes | 1,296 (86%) | 218 (14%) | |
Digestive system disease | |||
No | 8,180 (88%) | 1,099 (12%) | <.0001 |
Yes | 1,499 (83%) | 305 (17%) | |
Genitourinary system disease | |||
No | 7,407 (89%) | 957 (11%) | <.0001 |
Yes | 2,272 (84%) | 447 (16%) | |
Injury and poisoning | |||
No | 8,884 (88%) | 1,244 (12%) | <.0001 |
Yes | 795 (83%) | 160 (17%) | |
Respiratory disorders | |||
No | 9,255 (88%) | 1,269 (12%) | |
Yes | 424 (76%) | 135 (24%) | <.0001 |
Infection | |||
No | 9,392 (88%) | 1,258 (12%) | <.0001 |
Yes | 287 (66%) | 146 (34%) | |
Other circulatory disease | |||
No | 9,385 (88%) | 1,307 (12%) | <.0001 |
Yes | 294 (75%) | 97 (25%) | |
Benign neoplasm and in-situ cancer | |||
No | 9,356 (87%) | 1,365 (13%) | .2705 |
Yes | 323 (89%) | 39 (11%) | |
Other nervous system and sense organs disorder | |||
No | 9,366 (88%) | 1,336 (12%) | .0020 |
Yes | 313 (82%) | 68 (18%) | |
Skin and subcutaneous tissue disease | |||
No | 9,562 (88%) | 1,349 (12%) | <.0001 |
Yes | 117 (68%) | 55 (32%) | |
Musculoskeletal and connective tissue disease | |||
No | 8,551(88%) | 1,138 (12%) | <.0001 |
Yes | 1,128 (81%) | 266 (19%) | |
Other mental disorders | |||
No | 9,564 (87%) | 1,372 (13%) | .0008 |
Yes | 115 (78%) | 32 (22%) | |
Other anemias | |||
No | 9,563 (88%) | 1,350 (12%) | <.0001 |
Yes | 116 (68%) | 54 (32%) | |
Congenital anomalies | |||
No | 9,632 (87%) | 1,395 (13%) | .4427 |
Yes | 47 (84%) | 9 (16%) | |
Brain and other neurological disorders | |||
No | 9,606 (88%) | 1,366 (12%) | <.0001 |
Yes | 73 (66%) | 38 (34%) |
Frequency (row %) or Mean [SD]